Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nurix Therapeutics

11.44
-0.0300-0.26%
Post-market: 11.35-0.0900-0.79%18:22 EDT
Volume:548.63K
Turnover:6.31M
Market Cap:872.14M
PE:-4.08
High:11.66
Open:11.54
Low:11.29
Close:11.47
Loading ...
Oct 13, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 12, 2023

Major Issues Report

Form 8-K - Current report
Sep 07, 2023

Major Issues Report

Form 8-K - Current report
Jul 13, 2023

Major Issues Report

Form 8-K - Current report
Jul 13, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 04, 2023

Major Issues Report

8-K - Current report
Apr 13, 2023

Major Issues Report

8-K - Current report
Apr 13, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 10, 2023

Major Issues Report

8-K - Current report
Mar 13, 2023

Major Issues Report

8-K - Current report
Feb 24, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 09, 2023

Major Issues Report

8-K - Current report
Feb 09, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 09, 2023

Major Issues Report

8-K - Current report
Dec 16, 2022

Major Issues Report

8-K - Current report